Egypt Digital Therapeutics Market Analysis Report 2022 to 2030

Egypt Digital Therapeutics Market Analysis

$ 3999

Egypt Digital Therapeutics Market is at around $17 Mn in 2023 and is projected to reach $99.43 Mn in 2030, exhibiting a CAGR of 28.7 % during the forecast period. The development of healthcare infrastructure, provider acceptance, and partnerships and collaborations are driving market expansion. The market is dominated by key players like Omada Health Inc., DarioHealth Corp., 2Morrow Inc., Livongo Health Inc., WellDoc, Propeller Health, Canary Health, Noom Inc., Akili Interactive Labs Inc., and Hygieia.

ID: IN10EGDH006 CATEGORY: Digital Health GEOGRAPHY: Egypt AUTHOR: Aneri Parekh

Buy Now

Egypt Digital Therapeutics Market Executive Summary

Egypt Digital Therapeutics Market is at around $17 Mn in 2023 and is projected to reach $99.43 Mn in 2030, exhibiting a CAGR of 28.7 % during the forecast period.

The Egyptian market for digital therapeutics provides evidence-based therapeutic interventions for the treatment of a range of medical diseases through the use of digital technology, including software and mobile applications. This new industry seeks to enhance conventional medical practices by providing individualized and easily accessible solutions that enhance patient results. Digital therapeutics are essential to transforming the way medical interventions are delivered and advancing improved health outcomes in Egypt as the nation adopts new technologies in healthcare.

The growing use of digital health solutions is fueling the considerable expansion of the Egypt Digital Therapeutics Market. The market is expanding as a result of greater emphasis on preventive healthcare and increased awareness of chronic diseases. The ongoing development and integration of digital therapies in Egypt are further supported by government initiatives and collaborations between technology businesses and healthcare providers.

The global digital therapy market generated $6.2 Bn in sales in 2023, growing at an impressive rate. Modern technology and cost-effective manufacturing methods have brought about a tremendous transition that has resulted in amazing growth for this firm. This illustrates the growing use of digital medications in the medical field. The market trend suggests that further changes could be ahead, as innovations are needed to maintain the industry's steady growth.

Digital therapeutics startup Omada Health creates and administers clinically proven treatment plans for long-term ailments like type 2 diabetes, high blood pressure, and musculoskeletal pain. The company's solutions assist patients in managing their diseases and achieving better health outcomes by combining behavioral therapy, online coaching, and educational materials.

Egypt digital therapeutics market

Market Dynamics

Market Growth Drivers:

Collaborations and Partnerships: The industry is expanding as a result of the growing alliances and partnerships between well-known providers of digital therapies and employers, healthcare providers, and other stakeholders.

Development of Healthcare Infrastructure: Digital therapeutics' incorporation into the larger healthcare ecosystem can be facilitated by advancements in the infrastructure, such as electronic health record systems and communication networks.

Acceptance by Providers: The broad implementation of digital treatments depends on the approval of medical professionals, such as doctors and other healthcare providers. Programs for training and education aid in this acceptance.

Market Restraints:

Regulatory Obstacles: The adoption of healthcare innovations is significantly influenced by regulatory frameworks. Egypt's clearance procedure and market entry for digital therapies could be slowed if the norms are unclear.

Cultural and Social Factors: The adoption and use of digital therapies may be influenced by cultural values and societal perspectives on healthcare. One major obstacle that can be encountered is resistance to change, particularly in conventional healthcare practices.

Affordability and Accessibility: In a nation where there are economic differences, the price of digital treatments and the availability of the devices required to employ these technologies may provide difficulties. Certain population segments may not be able to access digital therapies due to financial constraints.

Healthcare Policies and Regulatory Landscape

Under the Egyptian Ministry of Health (MOH), the Egyptian Drug Authority (EDA) is the pharmaceutical regulatory organization tasked with ensuring the safety and efficacy of pharmaceutical products to protect public health. Applicants must provide sufficient documentation from each party attesting to the product's safety and efficacy for the uses specified in the suggested labeling to the Egyptian Drug Authority to legally market pharmaceuticals in Egypt. Applicant confusion and bureaucracy may result from the complex network of paperwork, departments, and procedures involved. Navigating this bureaucratic maze successfully often requires the knowledge and experience of local experts who are acquainted with the quirks and customs of the country.

Competitive Landscape

Key Players:

Omada Health Inc.
DarioHealth Corp.
2Morrow Inc.
Livongo Health Inc.
WellDoc
Propeller Health
Canary Health
Noom Inc.
Akili Interactive Labs Inc.
Hygieia

1. Executive Summary
1.1 Digital Health Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Digital Health Policy in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Egypt Digital Therapeutics Market Segmentation

By Solution

Software
Services

By Deployment

Cloud-based
On-premises

By Application

Therapy
Diabetes
Obesity
CNS
Respiratory
CVD

By End-use

Diagnostic Centres
Healthcare Players
Healthcare Research Centres
Hospitals & Clinics
Nursing Care Centres
Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.